NPB peer analysis
Northpointe Bancshares (NPB) against its competitors: price, today's move, 1-year return and market value side by side.
- NPB's peers: ALXO (ALX Oncology), BNR (Burning Rock), CCCC (C4 Therapeutics), CGEM (Cullinan Therapeutics), ERAS (Erasca), LEGN (Legend Biotech), ZLAB (Zai Lab).
NPB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.06 | 3.92% | -27.89% | $137.03M |
| BNR Burning Rock | $13.32 | 1.91% | -6.92% | $14.05M |
| CCCC C4 Therapeutics | $2.37 | -2.86% | -5.19% | $311.26M |
| CGEM Cullinan Therapeutics | $8.96 | -1.21% | 6.04% | $581.69M |
| ERAS Erasca | $13.74 | -3.38% | 397.83% | $4.82B |
| LEGN Legend Biotech | $15.44 | -4.10% | -44.86% | $2.86B |
| ZLAB Zai Lab | $21.03 | -4.06% | 2.59% | $2.37B |
| NPB Northpointe Bancshares | $14.50 | -1.02% | -8.75% | $501.44M |